PTPRC and neoplasm: In contrast, interestingly, in the TC1 tumor model, AIMS(EPT, R848, PTX) treatment increased PD‐1 expression in CD3+ cells, whereas there was no statistically significant increase in PD‐L1 expression in CD45− cells (Figure 8h,I; Figure S18b, Supporting Information).